Camden National (CAC) Director Rebecca Hatfield Adds 383 Shares
Rhea-AI Filing Summary
Camden National Corporation (CAC) – Form 4 insider filing
Director Rebecca Hatfield reported a routine, open-market acquisition of 383 common shares on 20 June 2025 at an average price of $38.57 per share. The shares were issued under the company’s 2022 Equity and Incentive Plan in lieu of cash director fees. Following the transaction, Hatfield’s direct beneficial ownership increased to 6,932.06 shares.
The filing contains no derivative activity, no sales, and no indication of a 10b5-1 trading plan. No other officers or directors are listed. Given the small dollar value (~$15k) and the compensatory nature of the grant, the filing is considered routine with limited market impact, but it nevertheless signals continuing alignment between the director and shareholders through incremental equity ownership.
Positive
- Director increased equity stake by 383 shares, reflecting ongoing insider confidence and alignment with shareholders.
Negative
- None.
Insights
TL;DR: Routine director share grant signals mild insider alignment; immaterial to valuation.
The Form 4 shows Director Hatfield accepted equity instead of cash compensation—383 shares at $38.57, lifting her stake to roughly 6.9k shares. Total consideration is about $14.8k, less than 0.01 % of CAC’s market cap, so it should not influence earnings forecasts or book value. While insider buying is directionally positive, the magnitude is too small to change institutional sentiment or model assumptions.
TL;DR: Equity-for-fees grant aligns board incentives; governance neutral.
Issuing stock under the 2022 Incentive Plan instead of cash supports shareholder-friendly pay practices by fostering ownership among directors. No red flags such as accelerated vesting, option repricing, or derivative hedging appear. Governance impact is neutral to modestly positive, but immaterial to proxy voting recommendations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 383 | $38.57 | $15K |
Footnotes (1)
- [object Object]